AIHealthcare Analytics

Overview

AI is being adopted in clinical study build workflows to accelerate study design and execution, but effective implementation requires careful attention to automation boundaries, standards compliance, and traceability requirements.

Five Considerations Framework

ClinicalTrialsArena published a sponsored analysis identifying five key considerations for adopting AI in clinical study build workflows (article 58). The framework emphasizes that AI can accelerate study-build foundations, but only when teams combine targeted automation with standards adherence, traceability, and human control. This framing cautions against over-automation and positions AI as an accelerant rather than a replacement for rigorous clinical trial methodology.

Implementation Context

The five considerations framework addresses a practical gap: clinical trial teams eager to adopt AI often lack structured guidance on where automation is appropriate and where human oversight is essential. Standards compliance (e.g., CDISC, ICH E6) and audit traceability are non-negotiable in regulated clinical research, creating boundaries that AI implementations must respect. This context makes clinical trials a particularly instructive case for AI governance more broadly.